{"id":790860,"date":"2024-11-26T09:51:40","date_gmt":"2024-11-26T14:51:40","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/abacus-life-targets-close-of-the-acquisition-of-carlisle-management-company-s-c-a-for-december-2-2024-with-receipt-of-regulatory-non-objection\/"},"modified":"2024-11-26T09:51:40","modified_gmt":"2024-11-26T14:51:40","slug":"abacus-life-targets-close-of-the-acquisition-of-carlisle-management-company-s-c-a-for-december-2-2024-with-receipt-of-regulatory-non-objection","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/abacus-life-targets-close-of-the-acquisition-of-carlisle-management-company-s-c-a-for-december-2-2024-with-receipt-of-regulatory-non-objection\/","title":{"rendered":"Abacus Life Targets Close of the Acquisition of Carlisle Management Company S.C.A. for December 2, 2024 with Receipt of Regulatory Non-Objection"},"content":{"rendered":"
\n

ORLANDO, Fla., Nov. 26, 2024 (GLOBE NEWSWIRE) — Abacus Life, Inc. (\u201cAbacus\u201d or the \u201cCompany\u201d) (NASDAQ: ABL), a pioneering global alternative asset manager specializing in leveraging longevity data and actuarial technology to offer uncorrelated investment opportunities, announced it has received regulatory non-objection from the Luxembourg Commission de Surveillance du Secteur Financier<\/em> (\u201cCSSF\u201d) for the acquisition of Carlisle Management Company S.C.A. (\u201cCarlisle\u201d), a leading Luxembourg-based investment fund manager in the life settlement space.<\/p>\n

\u201cWe are thrilled to be able to move forward with the closing of the Carlisle acquisition by the end of the fourth quarter, as we have previously communicated,\u201d said Abacus Life CEO Jay Jackson. \u201cCarlisle will add approximately $2.0 billion in assets under management to our ABL Wealth division, and its clients will be able to take full advantage of access to our uncorrelated, high-returning asset class of insurance products. We expect Carlisle\u2019s addition to be a major milestone in our path toward expanding our global alternative asset management footprint.\u201d<\/p>\n

Since 2008, Carlisle\u2019s team has been at the forefront of the life settlement industry, establishing a new standard for transparent transactions, maintaining integrity, and creating exceptional opportunities for life settlement investors and policyholders. Carlisle is licensed as an Alternative Investment Fund Manager under the supervision of the CSSF in Luxembourg, the second largest domicile for investment funds in the world.<\/p>\n

\n About Abacus<\/strong>\n <\/p>\n

Abacus is a pioneering global alternative asset manager and market maker specializing in uncorrelated financial products. The company leverages its proprietary, cutting-edge longevity data and actuarial technology to purchase life insurance policies from consumers seeking liquidity. This creates a high-return asset class uncorrelated to market fluctuations for institutional investors.<\/p>\n

With nearly $3 billion in assets under management, including pending acquisitions, Abacus is the only publicly traded global alternative asset manager focused on lifespan-based financial products.<\/p>\n

Abacus is expanding its leading expertise in longevity and lifespan into new growth areas:<\/p>\n